Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.annonc.2022.07.1876
dc.identifier.other
dc.description.volume
33
dc.description.issue
7
7
7
Publisher
DOI
10.1016/j.annonc.2022.07.1876